Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$5.12 - $14.5 $181,007 - $512,618
-35,353 Reduced 50.06%
35,263 $183,000
Q3 2021

Nov 16, 2021

BUY
$12.9 - $16.83 $147,447 - $192,366
11,430 Added 19.31%
70,616 $1.02 Million
Q2 2021

Aug 16, 2021

BUY
$13.28 - $18.45 $785,990 - $1.09 Million
59,186 New
59,186 $1 Million

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $12.7M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.